Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · IEX Real-Time Price · USD
2.135
+0.230 (12.07%)
At close: Jul 26, 2024, 4:00 PM
2.110
-0.025 (-1.17%)
After-hours: Jul 26, 2024, 7:33 PM EDT
PACB Market Cap
PACB has a market cap or net worth of $581.48 million as of July 26, 2024. Its market cap has decreased by -83.15% in one year.
Market Cap
581.48M
Enterprise Value
950.63M
1-Year Change
-83.15%
Ranking
Category
Stock Price
$2.14
Market Cap Chart
Since October 27, 2010, PACB's market cap has decreased from $823.90M to $581.48M, a decrease of -29.42%. That is a compound annual growth rate of -2.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 518.80M | -80.23% |
| Dec 29, 2023 | 2.62B | 41.85% |
| Dec 30, 2022 | 1.85B | -59.02% |
| Dec 31, 2021 | 4.51B | -3.45% |
| Dec 31, 2020 | 4.67B | 494.29% |
| Dec 31, 2019 | 786.60M | -28.61% |
| Dec 31, 2018 | 1.10B | 259.04% |
| Dec 29, 2017 | 306.90M | -12.84% |
| Dec 30, 2016 | 352.10M | -65.19% |
| Dec 31, 2015 | 1.01B | 80.82% |
| Dec 31, 2014 | 559.40M | 61.68% |
| Dec 31, 2013 | 346.00M | 262.30% |
| Dec 31, 2012 | 95.50M | -37.79% |
| Dec 30, 2011 | 153.50M | -81.73% |
| Dec 31, 2010 | 840.40M | 2.00% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 541.47M |
| Y-mAbs Therapeutics | 541.07M |
| Fulcrum Therapeutics | 537.01M |
| PureTech Health | 536.26M |
| Castle Biosciences | 533.10M |
| Enhabit | 516.11M |
| Third Harmonic Bio | 514.33M |
| COMPASS Pathways | 509.84M |